Protagenic Therapeutics Stock Price History
| PTIXW Stock | USD 0 0.00 0.00% |
If you're considering investing in Protagenic Stock, it is important to understand the factors that can impact its price. As of today, the current price of Protagenic Therapeutics stands at 0, as last reported on the 22nd of March, with the highest price reaching 0 and the lowest price hitting 0 during the day. Protagenic Therapeutics appears to be out of control, given 3 months investment horizon. Protagenic Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0135, which implies the firm had a 0.0135 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Protagenic Therapeutics, which you can use to evaluate the volatility of the company. Please evaluate Protagenic Therapeutics' Semi Deviation of 20.4, risk adjusted performance of 0.0217, and Coefficient Of Variation of 7390.29 to confirm if our risk estimates are consistent with your expectations.
Protagenic Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Protagenic |
Sharpe Ratio = 0.0135
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PTIXW | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 27.27 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.37 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 1 99% of assets perform better |
Based on monthly moving average Protagenic Therapeutics is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Protagenic Therapeutics by adding it to a well-diversified portfolio.
Protagenic Therapeutics Stock Price History Chart
There are several ways to analyze Protagenic Stock price data. The simplest method is using a basic Protagenic candlestick price chart, which shows Protagenic Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Protagenic Stock Price History Data
The price series of Protagenic Therapeutics for the period between Sun, Dec 22, 2024 and Sat, Mar 22, 2025 has a statistical range of 0.0 with a coefficient of variation of 28.12. The price distribution for the period has arithmetic mean of 0.01. The median price for the last 90 days is 0.01.| Open | High | Low | Close | Volume | ||
03/22/2025 | 0 | 0 | 0 | 0 | ||
| 03/13/2025 | 0 | 0 | 0 | 0 | 67,029 | |
| 03/11/2025 | 0 | 0 | 0 | 0 | 1.00 | |
| 03/10/2025 | 0.01 | 0.01 | 0 | 0 | 589.00 | |
| 03/07/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 1,000.00 | |
| 03/06/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 2,837 | |
| 03/05/2025 | 0.01 | 0.01 | 0 | 0.01 | 12,542 | |
| 03/04/2025 | 0.01 | 0.01 | 0 | 0.01 | 62,764 | |
| 02/27/2025 | 0 | 0 | 0 | 0 | 1,000.00 | |
| 01/29/2025 | 0 | 0.01 | 0 | 0 | 1.00 | |
| 01/28/2025 | 0 | 0 | 0 | 0 | 40,119 | |
| 01/14/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
| 01/13/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 1,068 | |
| 12/30/2024 | 0.01 | 0.01 | 0 | 0 | 10.00 | |
| 12/26/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 7.00 | |
| 12/24/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1,100 | |
| 12/23/2024 | 0.01 | 0.01 | 0 | 0.01 | 36,550 | |
| 12/20/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 12,600 | |
| 12/19/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 200.00 | |
| 12/18/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 61,256 | |
| 12/11/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
| 12/09/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 150.00 | |
| 12/05/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 60,251 | |
| 12/04/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 340.00 | |
| 12/02/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 43,150 | |
| 11/29/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 36,300 | |
| 11/27/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 10,850 | |
| 11/26/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 20.00 | |
| 11/25/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 7,097 | |
| 11/08/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
| 11/07/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 12,100 | |
| 11/06/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 19,000 | |
| 10/25/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 13,572 | |
| 09/26/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
| 09/24/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 300.00 | |
| 09/19/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 36,548 | |
| 09/16/2024 | 0.02 | 0.02 | 0.02 | 0.02 | 300.00 | |
| 09/11/2024 | 0.01 | 0.02 | 0.01 | 0.02 | 51,534 | |
| 09/06/2024 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
| 09/05/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 8,452 | |
| 08/30/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 101.00 | |
| 08/29/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1,575 | |
| 08/27/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 100.00 | |
| 08/26/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 4,779 | |
| 08/19/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
| 08/16/2024 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
| 08/15/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 9,558 | |
| 08/13/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 7,501 | |
| 08/09/2024 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
| 08/08/2024 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
| 08/07/2024 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
| 08/06/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
| 08/05/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 100.00 | |
| 08/02/2024 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
| 08/01/2024 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
| 07/31/2024 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
| 07/30/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
| 07/15/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
| 07/09/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
| 07/01/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 4,102 | |
| 06/28/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 11,009 |
About Protagenic Therapeutics Stock history
Protagenic Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Protagenic is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Protagenic Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Protagenic Therapeutics stock prices may prove useful in developing a viable investing in Protagenic Therapeutics
Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company was founded in 2016 and is based in New York, New York. Protagenic Therapeutics is traded on NASDAQ Exchange in the United States.
Protagenic Therapeutics Stock Technical Analysis
Protagenic Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
Protagenic Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Protagenic Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Protagenic Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Protagenic to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0217 | |||
| Jensen Alpha | 0.4852 | |||
| Total Risk Alpha | 2.43 | |||
| Sortino Ratio | 0.0141 | |||
| Treynor Ratio | 0.1916 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Protagenic Stock Analysis
When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.